Archean Chemical Industries Limited (NSE:ACI)
India · Delayed Price · Currency is INR 417.00
-7.70 (-1.81%)
Nov 6, 2026, 3:29 PM IST
NSE:ACI Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 11,801 | 10,811 | 10,410 | 13,301 | 14,411 | 11,304 | |
Revenue Growth | 5.99% | 3.85% | -21.73% | -7.70% | 27.48% | 52.60% |
Cost of Revenue | 1,078 | 805.78 | 91.96 | 1,124 | 192.41 | 537.06 |
Gross Profit | 10,723 | 10,005 | 10,318 | 12,177 | 14,218 | 10,767 |
Selling, General & Admin | 928.26 | 896.98 | 746.95 | 836 | 795.61 | 462.37 |
Other Operating Expenses | 7,436 | 6,716 | 6,422 | 6,699 | 7,083 | 5,596 |
Operating Expenses | 9,299 | 8,542 | 7,963 | 8,239 | 8,565 | 6,727 |
Operating Income | 1,424 | 1,462 | 2,355 | 3,938 | 5,654 | 4,040 |
Interest Expense | -229.18 | -234.93 | -66.73 | -69.21 | -940.09 | -1,609 |
Interest & Investment Income | 41.9 | 41.9 | 31.13 | 21.21 | 41.36 | 13.62 |
Currency Exchange Gain (Loss) | 133.13 | 133.13 | 104.44 | 79.05 | 127.76 | 23.9 |
Other Non Operating Income (Expenses) | -64.19 | -16.69 | -10.18 | 41.51 | 38.84 | 28.76 |
EBT Excluding Unusual Items | 1,306 | 1,386 | 2,414 | 4,011 | 4,922 | 2,497 |
Gain (Loss) on Sale of Investments | 61.65 | 61.65 | 228.63 | 231.02 | 37.8 | 12.59 |
Gain (Loss) on Sale of Assets | -0.13 | -0.13 | -4.24 | -0.36 | 0.55 | 0.21 |
Other Unusual Items | - | - | -401.83 | - | - | - |
Pretax Income | 1,391 | 1,471 | 2,238 | 4,272 | 5,117 | 2,510 |
Income Tax Expense | 412.18 | 416.88 | 616.22 | 1,082 | 1,291 | 628.04 |
Earnings From Continuing Operations | 979.12 | 1,054 | 1,621 | 3,190 | 3,826 | 1,882 |
Minority Interest in Earnings | 24.05 | 14.51 | 0.04 | 0.07 | - | - |
Net Income | 1,003 | 1,069 | 1,621 | 3,190 | 3,826 | 1,882 |
Net Income to Common | 1,003 | 1,069 | 1,621 | 3,190 | 3,826 | 1,882 |
Net Income Growth | -41.26% | -34.10% | -49.17% | -16.62% | 103.26% | 182.57% |
Shares Outstanding (Basic) | - | 123 | 123 | 123 | 110 | 103 |
Shares Outstanding (Diluted) | - | 124 | 124 | 123 | 111 | 103 |
Shares Change | - | -0.00% | 0.17% | 11.47% | 7.10% | - |
EPS (Basic) | - | 8.66 | 13.14 | 25.90 | 34.66 | 18.22 |
EPS (Diluted) | - | 8.65 | 13.12 | 25.87 | 34.59 | 18.22 |
EPS Growth | - | -34.07% | -49.29% | -25.21% | 89.85% | 182.50% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -3,324 | -2,425 | -873.38 | 1,715 | 3,962 | 2,179 |
Free Cash Flow Per Share | - | -19.64 | -7.07 | 13.91 | 35.82 | 21.10 |
Dividend Per Share | - | 2.500 | 3.000 | 3.000 | 2.500 | - |
Dividend Growth | - | -16.67% | 0% | 20.00% | - | - |
Gross Margin | 90.87% | 92.55% | 99.12% | 91.55% | 98.67% | 95.25% |
Operating Margin | 12.07% | 13.53% | 22.62% | 29.61% | 39.23% | 35.74% |
Profit Margin | 8.50% | 9.88% | 15.58% | 23.98% | 26.55% | 16.65% |
Free Cash Flow Margin | -28.16% | -22.43% | -8.39% | 12.89% | 27.50% | 19.28% |
EBITDA | 2,249 | 2,281 | 3,066 | 4,577 | 6,258 | 4,639 |
EBITDA Margin | 19.06% | 21.10% | 29.45% | 34.41% | 43.43% | 41.04% |
D&A For EBITDA | 824.26 | 818.59 | 711.15 | 638.25 | 604.12 | 599.51 |
EBIT | 1,424 | 1,462 | 2,355 | 3,938 | 5,654 | 4,040 |
EBIT Margin | 12.07% | 13.53% | 22.62% | 29.61% | 39.23% | 35.74% |
Effective Tax Rate | 29.63% | 28.34% | 27.54% | 25.33% | 25.23% | 25.02% |
Revenue as Reported | 12,023 | 11,080 | 10,783 | 13,734 | 14,843 | 11,428 |